| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atherosclerosis and Lipoproteins |
From the Institute for Experimental Animals (M.S., T.I., S.Y.), Kobe University School of Medicine, and Division of Cardiovascular and Respiratory Medicine (S.K.), Kobe University Graduate School of Medicine, Kobe, Japan, and Department of Pathology (J.F.), Institute of Basic Medical Science, University of Tsukuba, Tsukuba, Japan.
Correspondence to Masashi Shiomi, PhD, Institute for Experimental Animals, Kobe University School of Medicine, 7-51, Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan. E-mail ieakusm{at}med.kobe-u.ac.jp
| Abstract |
|---|
|
|
|---|
Methods and Results WHHLMI rabbits were characterized by the high incidence of fatal myocardial infarction at ages 11 to 35 months, being increased from 23% to 97% after the selective breeding. The ECG on WHHLMI rabbits showed a typical feature of myocardial infarction. Histological examination of hearts from suddenly deceased WHHLMI rabbits revealed old myocardial infarction accompanied by fresh myocardial lesions. The culprit coronary arteries exhibited severe atheromatous plaques (>90% lumen area stenosis), suggesting that coronary atherosclerosis is responsible for myocardial infarction observed in WHHLMI rabbits. In addition, the coronary plaques showed vulnerable features including macrophage-rich thin cap and large necrotic core.
Conclusions To the best of our knowledge, this is the first report of spontaneous myocardial infarction in rabbits, and it is suggested that this WHHLMI rabbit strain will be a useful animal model to study human myocardial infarction.
Key Words: coronary atherosclerosis myocardial infarction vulnerable plaque WHHLMI rabbit
| Introduction |
|---|
|
|
|---|
In 1980, our institute developed Watanabe heritable hyperlipidemic (WHHL) rabbits as a suitable animal model for human familial hypercholesterolemia and atherosclerosis.6 Based on this strain, we additionally developed coronary atherosclerosis-prone WHHL rabbits, a variant strain, which have higher low-density lipoprotein cholesterol and typical coronary atheromatous plaques similar to those of humans.7 However, the incidence of spontaneous myocardial infarction in coronary atherosclerosisprone WHHL rabbits was extremely low, which limits their use in the study of myocardial infarction. Since 1994, we have attempted to develop an animal model for spontaneous myocardial infarction by serial and selective breeding of the coronary atherosclerosisprone WHHL rabbits. After 6 years of the selective breeding, we developed a new WHHL strain for spontaneous myocardial infarction and named this myocardial infarctionprone WHHL rabbit strain the WHHLMI rabbit. In this study, we performed a pathological analysis on the hearts of suddenly deceased WHHLMI rabbits and demonstrated that WHHLMI rabbits are potentially useful for the study of myocardial infarction.
| Methods |
|---|
|
|
|---|
Selective Breeding
To develop a rabbit model for spontaneous myocardial infarction, we selected descendants of coronary atherosclerosis-prone WHHL rabbits7 with the following features: (1) development of myocardial infarction; (2) macrophage-rich coronary plaque; (3) coronary lumen stenosis greater than the values of the mean plus the standard error in their parents generation; and (4) plasma total cholesterol levels >21 mmol/L at 12 months old and greater than 18 mmol/L at 24 months old. Using these breeding stocks, we carried out selective breeding and obtained 5 to 7 generations of this colony during 6 years. During the selective breeding, the conditions of housing, feeding, and others were maintained constant and rabbits did not receive any interventions except the selective breeding.
Histological Analysis
We examined 201 WHHL rabbits during the selective breeding. We estimated elapsing time up to excision of hearts after decease based on daily observation of rabbits health at 9:00 AM, 1:00 PM, and 5:00 PM in addition to regular care. After the sudden death of rabbits, the hearts were excised within 30 minute to 16 hours. According to the method reported previously,7 the immersion-fixed hearts with 10% buffered neutral formalin solution, Bouins fixative, or periodate-lysine-paraformaldehyde fixative were cut into 6 blocks and were embedded in paraffin. To examine atherosclerotic plaques of the upstream coronary arteries associated with the myocardial lesions, we prepared 4 paraffin blocks of the upper quarter of the heart (from the base of the heart) containing the main stem of the left coronary artery, the origin portion of the right coronary artery, or the left circumflex artery (LCX) in addition to the left anterior descending artery (LAD), left septal artery (LSP), and right coronary arteries, respectively. Using these blocks, coronary arteries were sectioned at 500-µm intervals transversely. The remainder (the 3 quarters of the apex site) was cut into 2 blocks. These 2 blocks were sectioned at 1000-µm intervals transversely for the observation of myocardial lesions. Sections were stained with H&E staining, elastic van Gieson staining, Azan-Mallory staining, or immunohistochemically using mouse monoclonal antibodies for smooth muscle actins (1A4; Dako A/S) and for rabbit macrophages (RAM-11; Dako A/S). Immunohistochemical staining was carried out using the Vectastain ABC kit (Vector Laboratories Inc) with hematoxylin counterstaining. The degree of coronary stenosis was expressed as the percent lumen area stenosis evaluated by 2 independent researchers. The lesion stage of myocardial infarction in rabbits was evaluated by the method of Schoen.8
Monitoring of the ECG
To examine whether the ECG showed representative changes of myocardial infarction, we monitored each WHHLMI rabbit (>12 months old) with the ECG monthly under anesthesia by intravenous injection of ketamine hydrochloride (10 mg/kg) and xylazine hydrochloride (3 mg/kg). ECG was monitored using unipolar leads and extremity leads using a Polygraph System RM-6000 equipped with a bioelectric amplifier AB-621G (Nihon-Kohden Co), and measurements were performed with PowerLab/8SP (AD Instruments Japan Inc).
Statistical Analyses
Values were expressed as mean±SEM. Statistical analyses were carried out using Fishers exact probability test for incidence, using the Mann-Whitney U test for coronary stenosis, and using Students t test or Aspin-Welchs t test for serum lipid levels. Statistical significance was set at P<0.05.
| Results |
|---|
|
|
|---|
|
Myocardial Lesions of WHHLMI Rabbits
The myocardial lesions were widely distributed from the left ventricle, right ventricle, and ventricular septum, where coronary arteries showed severe coronary stenosis (see below). Based on the anatomical location, myocardial infarction is classified into subendocardial infarction, intramural infarction, transmural infarction, and subepicardial infarction. In many WHHLMI rabbits, old myocardial infarction with pathological features equivalent to chronic myocardial infarction was often observed, which was accompanied by fresh myocardial lesions (combined myocardial infarction) (Figure 1). Fresh myocardial lesions consisted of hyperemia (panel A), eosinophilic myocardial cells (panel B), and infiltration of inflammatory cells (panel C). These findings were observed in the vicinity of myocardial fibrosis at the subendocardial zone. Figure 2 shows old myocardial infarction. In the old myocardial lesions, there was a prominent calcification (panel A) and subepicardial infarction (panel B), which is frequently found in old myocardial infarction in humans. In addition, there was dissolution of myocardial cells and replacement of fibrosis at the posterior right region (panel A) and ventricular septum (panel C). The left ventricle wall was thinned (panels A, C, and D), and a transmural myocardial lesion was observed at the lateral wall (panel D). In classical WHHL rabbits before selective breeding, the myocardial lesions were small (focal or patchy) and the lesions were limited at the subendocardial region or periarterial region. We did not detect any transmural lesions or subepicardial infarction in addition to myocardial calcification. Therefore, after selective breeding, myocardial lesions became more extensive and advanced.
|
|
Proximal Atheromatous Plaque of the Culprit Coronary Arteries
Because myocardial infarction was present in all WHHLMI rabbits, we next examined the coronary atherosclerotic lesions in terms of distribution, stenosis, severity, and stability of the lesions. As summarized in Figure 3, atherosclerotic lesions were found in all upstream coronary arteries associated with the myocardial lesions; the most severe coronary branch was the LCX followed by LSP, LAD, and RCA. In the LCX, 73% of sections showed atheromatous plaques having >90% lumen area stenosis. In addition, the frequency of coronary lesions with >70% area stenosis was 97.2% in the LCX, 54.7% in the LAD, and 59.2% in the LSP, respectively. These findings suggest that the serial advanced atheromatous plaques observed in the upstream culprit coronary arteries were related to myocardial lesions as described above.
|
The culprit plaques of the LCX are either foam cellrich or matrix-rich plaques that produce a marked lumen stenosis or concentric occlusion (Figure I, available online at http://atvb.ahajournals.org). The typical plaques were frequently found in large branches and were associated with complicated changes, including calcification (Figure I, panel B) and intraplaque hemorrhage (Figure I, panel C ). In some lesions, the plaque was extremely fragile (Figure 4); they had a thin cap (panel A and B), beneath which there were accumulating macrophages, lipid cores, and calcium deposits (panel D) but few smooth muscle cells (panel C). Despite such vulnerable plaques, we were unable to detect the real rupture or thrombus formation in any coronary plaques of WHHLMI rabbits.
|
ECG of a WHHLMI Rabbit
The electrocardiograms from a WHHLMI rabbit monitored immediately before sudden decease (Figure II, available online at http://atvb.ahajournals.org) showed the typical change of acute myocardial infarction in humans. These features on the ECG were never recorded when rabbits were injected an overdose anesthetic for euthanasia. More over, we also recorded the ECG of classical WHHL rabbits but did not find the pattern of myocardial infarction (data not shown).
| Discussion |
|---|
|
|
|---|
Almost all myocardial lesions of WHHLMI rabbits were old myocardial infarctions accompanied by fresh myocardial lesions (Figure 1). The myocardial lesions were mainly observed at the subendocardial region circumferentially (Figure 2), and the related culprit coronary arteries located at the upper stream showed advanced atheromatous plaques with >90% stenosis in the serial sections (Figure 3). This suggests that serial nearly occluded coronary lesions related to the development of myocardial infarctions. In autopsied human hearts, multivessel disease was frequently encountered in the subendocardial infarction because of chronic insufficient blood supply.9,10 Therefore, the features of myocardial lesions of WHHLMI rabbits may resemble those of patients with multivessel coronary disease.
In several plaques of the culprit coronary arteries, the fibrous cap was thin and macrophage accumulation was prominent at the plaque surface (Figure 4 and Figure I). Macrophage-rich coronary plaque was a feature of WHHLMI rabbits and was distinct from the coronary plaques of WHHL rabbits before the selective breeding, in which the lesions were macrophage-poor and fibromuscular component-rich.11 Several coronary lesions showed nearly rupture features: thin fibrous cap below which a large lipid core and calcium accumulation were mixed with a large number of macrophages (Figure 4). In addition, we observed intraplaque hemorrhage, calcium accumulation, and occlusion of the coronary lumen with accumulation of macrophages (Figure I). These features are consistent with vulnerable plaques,1214 which may trigger plaque rupture and possibly potentiate acute coronary syndromes. Despite these observations, we did not detect any rupture or luminal thrombosis in the coronary plaques of WHHLMI rabbits. Previous studies reported by Nakamura et al15 demonstrated that coronary thrombosis was observed in WHHL rabbits (19-month-old average) treated with Russells viper venom in combination with angiotensin II but not in age-matched WHHL rabbits treated with saline or angiotensin II alone. Therefore, we considered that coronary thrombosis was not induced spontaneously in WHHL rabbits if coronary plaques did not rupture.
There are several possibilities for this outcome. First, the rabbit coronary lesions (macrophage number or functions and matrix components) may be insufficient to trigger the plaque rupture and subsequently lead to thrombus formation. Several factors such as matrix metalloproteinases, tissue factors, and lipoprotein (a) are considered to play major roles in triggering the plaque rupture and thrombus formation.1214 In future studies, we will crossbreed our WHHLMI rabbits with lipoprotein (a) transgenic rabbits, which have advanced atherosclerosis and calcification,16 or with macrophage-specific expression of metalloproteinase-12 transgenic rabbits (Fan J, et al, unpublished data, 2003). Therefore, it will be interesting to test these hypotheses by introducing these risk factors into WHHLMI rabbits. Second, the general stressless environment for WHHLMI rabbits, which is in contrast to humans exposed to multiple environmental conditions and risk factors (social stress, hypertension, diabetes, and smoking), may also protect the plaque from rupture. To test this hypothesis, we will expose WHHLMI rabbits to stressful environments in future studies. Having vulnerable plaques without detectable rupture or luminal thrombi suggests that old myocardial infarctions in WHHLMI rabbits were caused by progressing coronary occlusions; thus, acute coronary syndromes may be not manifested in these rabbits. Consistent with this notion, clinical studies showed that coronary thrombosis was not detected in patients with subendocardial infarction.9,10,1719
The areas of fresh myocardial lesions were small despite showing typical ST elevation in ECG (Figure II). WHHLMI rabbits, which we could monitor, deceased within 15 minute after a heart attack. Therefore, fresh myocardial infarction can hardly be observed under a light microscopy within such a short time. We observed many nuclei of myocardial cells with hollow, myolysis of myocardial cells, and intermyocardial edema in the hearts of WHHLMI rabbits excised within 30 minute after death (data not shown), although it is difficult to distinguish these findings from findings by artifacts. In addition, WHHLMI rabbits may decease from myocardial infarction directly or complications of the myocardial ischemia such as fatal arrhythmia or cardiogenic shock attributable to the coronary occlusion.
In conclusion, we successfully developed WHHLMI rabbits as a potential human myocardial infarction model. Coronary plaques with complicated lesions are the major determinant for the myocardial infarction found in these rabbits. It is suggested that WHHLMI rabbits will be a useful model for the study of human myocardial infarction and be particularly valuable to study the mechanism of chronic ischemia and plaque formation of coronary arteries. It is also possible that these WHHLMI rabbits can be used as a tool for the development of new therapeutic drugs and interventions. Efforts are being made toward investigating the mechanisms of plaque stability, and, hopefully, plaque rupture or acute coronary syndromes can be produced in WHHLMI rabbits through the introduction of other risk factors.
Limitation of this Study
Coronary plaque rupture and subsequent intravascular thrombosis are the major cause for acute coronary syndromes in humans,1214 whereas WHHLMI rabbits did not show these findings despite the presence of vulnerable coronary plaques. These observations indicate that the mechanisms for myocardial infarction in WHHLMI rabbits are different from those in humans. In addition, the features of WHHLMI rabbits suggest that additional risk factors other than vulnerable plaque may be required to trigger the rupture of coronary plaques. Therefore, we consider that WHHLMI rabbits will be a suitable model to elucidate risk factors for plaque rupture and the possible mechanisms.
| Acknowledgments |
|---|
Received January 20, 2003; accepted April 9, 2003.
| References |
|---|
|
|
|---|
2. Kuhlencordt PJ, Gyurko R, Han F, Scherrer-Crosbie M, Aretz TH, Hajjar R, Picard MH, Huang PL. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation. 2001: 104; 448454.
3. Braun A, Trigatti BL, Post MJ, Sato K, Simons M, Edelberg JM, Rosenberg RD, Schrenzel M, Krieger M. Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Cir Res. 2002; 90: 270276.
4. Fan J, Challah M, Watanabe T. Transgenic rabbit models for biomedical research: current status, basic methods, and future perspectives. Pathol Int. 1999; 49: 583594.[CrossRef][Medline] [Order article via Infotrieve]
5. Brousseau ME, Hoeg JM. Transgenic rabbits as models for atherosclerosis research. J Lipid Res. 1999; 40: 365375.
6. Watanabe Y. Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). Atherosclerosis. 1980; 36: 261268.[CrossRef][Medline] [Order article via Infotrieve]
7. Shiomi M, Ito T, Shiraishi M, Watanabe Y. Inheritability of atherosclerosis and the role of lipoproteins as risk factors in the development of atherosclerosis in WHHL rabbits: risk factors related to coronary atherosclerosis are different from those related to aortic atherosclerosis. Atherosclerosis. 1992; 96: 4352.[CrossRef][Medline] [Order article via Infotrieve]
8. Schoen, FJ. The heart. In: Cotran RS, Kumar V, Collins T, eds. Pathologic Basis of Disease. Sixth ed. Philadelphia: WB Saunders; 1999.
9. Kuwao S, Kameya T, Kasai K, Niitsuya M, Nishiyama Y. Characterization of transmural and subendocardial infarction by typing and grading of ischemic lesions in autopsied human hearts. Acta Pathol Jpn. 1992; 42: 476482.[Medline] [Order article via Infotrieve]
10. Nakagaki K. Coronary thrombosis and its role in the development of myocardial infarction [in Japanese]. Fukuoka Acta Medica. 1973; 68: 541561.
11. Shiomi M, Ito T, Tsukada T, Yata T, Ueda M. Cell compositions of coronary and aortic atherosclerotic lesions in WHHL rabbits differ: an immunohistochemical study. Arterioscler Thromb. 1994; 14: 931937.
12. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995; 92: 657671.
13. Davies MJ. Stability and instability: two faces of coronary atherosclerosis. Circulation. 1996; 94: 20132020.
14. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001; 104: 365372.
15. Nakamura M, Abe S, Kinukawa N. Aortic medial necrosis with or without thrombosis in rabbits treated with Russells ciper venom and angiotensin II. Atherosclerosis. 1997; 128: 149156.[CrossRef][Medline] [Order article via Infotrieve]
16. Sun H, Unoki H, Wang X, Liang J, Ichikawa T, Arai Y, Shiomi M, Marcovina SM, Watanabe T, Fan J. Lipoprotein(a) enhances advanced atherosclerosis in WHHL transgenic rabbits expressing human apolipoprotein(a). J Biol Chem. 2002; 277: 4748647492.
17. Davies MJ, Woolf N, Robertson WB. Pathology of acute myocardial infarction with particular reference to occlusive coronary thrombi. Br Heart J. 1976; 38: 659664.
18. Buja LM, Willerson JT. The role of coronary artery lesions in ischemic heart disease; Insights from recent clinicopathologic, coronary arteriographic and experimental studies. Hum Pathol. 1987; 18: 451461.[Medline] [Order article via Infotrieve]
19. Chapman I. The cause-effect relationship between recent coronary artery occlusion and acute myocardial infarction. Am Heart J. 1974; 87: 267271.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
T. Koike, S. Kitajima, Y. Yu, K. Nishijima, J. Zhang, Y. Ozaki, M. Morimoto, T. Watanabe, S. Bhakdi, Y. Asada, et al. Human C-Reactive Protein Does Not Promote Atherosclerosis in Transgenic Rabbits Circulation, November 24, 2009; 120(21): 2088 - 2094. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ishino, T. Mukai, Y. Kuge, N. Kume, M. Ogawa, N. Takai, J. Kamihashi, M. Shiomi, M. Minami, T. Kita, et al. Targeting of Lectinlike Oxidized Low-Density Lipoprotein Receptor 1 (LOX-1) with 99mTc-Labeled Anti-LOX-1 Antibody: Potential Agent for Imaging of Vulnerable Plaque J. Nucl. Med., October 1, 2008; 49(10): 1677 - 1685. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ogawa, Y. Magata, T. Kato, K. Hatano, S. Ishino, T. Mukai, M. Shiomi, K. Ito, and H. Saji Application of 18F-FDG PET for Monitoring the Therapeutic Effect of Antiinflammatory Drugs on Stabilization of Vulnerable Atherosclerotic Plaques J. Nucl. Med., November 1, 2006; 47(11): 1845 - 1850. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liang, E. Liu, Y. Yu, S. Kitajima, T. Koike, Y. Jin, M. Morimoto, K. Hatakeyama, Y. Asada, T. Watanabe, et al. Macrophage Metalloelastase Accelerates the Progression of Atherosclerosis in Transgenic Rabbits Circulation, April 25, 2006; 113(16): 1993 - 2001. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Newby Dual Role of Matrix Metalloproteinases (Matrixins) in Intimal Thickening and Atherosclerotic Plaque Rupture Physiol Rev, January 1, 2005; 85(1): 1 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ogawa, S. Ishino, T. Mukai, D. Asano, N. Teramoto, H. Watabe, N. Kudomi, M. Shiomi, Y. Magata, H. Iida, et al. 18F-FDG Accumulation in Atherosclerotic Plaques: Immunohistochemical and PET Imaging Study J. Nucl. Med., July 1, 2004; 45(7): 1245 - 1250. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Koike, J. Liang, X. Wang, T. Ichikawa, M. Shiomi, G. Liu, H. Sun, S. Kitajima, M. Morimoto, T. Watanabe, et al. Overexpression of Lipoprotein Lipase in Transgenic Watanabe Heritable Hyperlipidemic Rabbits Improves Hyperlipidemia and Obesity J. Biol. Chem., February 27, 2004; 279(9): 7521 - 7529. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |